NASDAQ:ISO - Nasdaq - US4650051067 - Common Stock - Currency: USD
NASDAQ:ISO (3/20/2023, 8:17:18 PM)
0.7616
+0.02 (+2.78%)
The current stock price of ISO is 0.7616 USD. In the past month the price decreased by -29.48%. In the past year, price decreased by -79.08%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
DHR | DANAHER CORP | 28.07 | 151.18B | ||
A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
WAT | WATERS CORP | 31.58 | 22.26B | ||
ICLR | ICON PLC | 14.39 | 16.63B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
RVTY | REVVITY INC | 23.23 | 13.85B | ||
AVTR | AVANTOR INC | 17.3 | 11.78B | ||
TEM | TEMPUS AI INC | N/A | 10.72B |
IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. The company is headquartered in Branford, Connecticut and currently employs 290 full-time employees. The company went IPO on 2021-10-08. The firm is engaged in building solutions to develop curative medicines and personalized therapeutics. The firm's single-cell proteomics systems reveal biological activity in small subsets of cells, allowing researchers to connect directly to in-vivo biology and develop precise and personalized therapies. Its focuses on developing applications of its platform for cancer immunology and cell and gene therapy. The firm's platform is comprised of IsoLight and IsoSpark instruments, IsoCode and CodePlex chip consumables, and IsoSpeak software. Its IsoLight and IsoSpark instruments are designed to be automated benchtop proteomic hubs. Its IsoCode chips use its technology proteomic barcoding to capture single-cell protein information. Its CodePlex chips technology is used to test multiplexed bulk proteins. The Company’s IsoSpeak software provides automated data analysis and accelerated insights with a push-button user interface.
ISOPLEXIS CORP
35 Ne Industrial Road
Branford CONNECTICUT US
CEO: Sean Mackay
Employees: 290
Company Website: https://isoplexis.com/
Phone: 12032084111.0
The current stock price of ISO is 0.7616 USD. The price increased by 2.78% in the last trading session.
The exchange symbol of ISOPLEXIS CORP is ISO and it is listed on the Nasdaq exchange.
ISO stock is listed on the Nasdaq exchange.
9 analysts have analysed ISO and the average price target is 1.63 USD. This implies a price increase of 114.29% is expected in the next year compared to the current price of 0.7616. Check the ISOPLEXIS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ISOPLEXIS CORP (ISO) has a market capitalization of 30.21M USD. This makes ISO a Nano Cap stock.
ISOPLEXIS CORP (ISO) currently has 290 employees.
ISOPLEXIS CORP (ISO) has a resistance level at 0.92. Check the full technical report for a detailed analysis of ISO support and resistance levels.
The Revenue of ISOPLEXIS CORP (ISO) is expected to grow by 49.37% in the next year. Check the estimates tab for more information on the ISO EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ISO does not pay a dividend.
ISOPLEXIS CORP (ISO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.7).
ChartMill assigns a fundamental rating of 3 / 10 to ISO. ISO may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ISO reported a non-GAAP Earnings per Share(EPS) of -2.7. The EPS decreased by -14.08% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 1.12 |
ChartMill assigns a Buy % Consensus number of 47% to ISO. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 48% and a revenue growth 49.37% for ISO